Literature DB >> 32068121

LncRNA HSPC324 plays role in lung development and tumorigenesis.

Meisam Jafarzadeh1, Mahmood Tavallaie1, Bahram M Soltani2, Sara Hajipoor3, Sayed Mostafa Hosseini4.   

Abstract

Lung cancer is a leading cause of cancer-related death in the world. Therefore, identifying the genes and molecular pathways involved in lung development and tumorigenesis can help us improve the therapeutic strategies of lung cancer. Accumulating evidence confirms that long noncoding RNAs, as a novel layer of regulatory RNA molecules, play an important role in various aspects of the cells. Here, using available high throughput gene expression data, we identified an lncRNA (HSPC324) with high expression level in lung tissue that is distinctly expressed in lung tumor tissues relative to normal. Using GO enrichment and KEGG pathway analyses, we further analyzed the functions and pathways involving the HSPC324-correlated genes. Ectopic expression of lncRNA HSPC324 significantly inhibited proliferation, cell cycle and migration; on the other hand, increased apoptosis and ROS production in lung adenocarcinoma cells. Overall, this study introduces HSPC324 as a new player in the development of lung cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; HSPC324; LncRNA; Lung adenocarcinoma

Mesh:

Substances:

Year:  2020        PMID: 32068121     DOI: 10.1016/j.ygeno.2020.02.012

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  A Prognostic Signature of Glycolysis-Related Long Noncoding RNAs for Molecular Subtypes in the Tumor Immune Microenvironment of Lung Adenocarcinoma.

Authors:  Na Li; Mu Su; Louyin Zhu; Li Wang; Yonggang Peng; Bo Dong; Liya Ma; Yongyu Liu
Journal:  Int J Gen Med       Date:  2021-11-27

2.  Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes.

Authors:  Qiang Chen; Jiakang Ma; Xiaoyi Wang; Xiangqing Zhu
Journal:  Aging (Albany NY)       Date:  2022-06-07       Impact factor: 5.955

Review 3.  CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer.

Authors:  Vahid Akbari Kordkheyli; Mohsen Rashidi; Yasaman Shokri; Samane Fallahpour; Atena Variji; Ehsan Nabipour Ghara; Sayed Mostafa Hosseini
Journal:  Adv Pharm Bull       Date:  2021-04-03

4.  Development of six immune-related lncRNA signature prognostic model for smoking-positive lung adenocarcinoma.

Authors:  Dajie Zhou; Jing Wang; Xiangdong Liu
Journal:  J Clin Lab Anal       Date:  2022-05-13       Impact factor: 3.124

5.  Genome-wide association study of asthma, total IgE, and lung function in a cohort of Peruvian children.

Authors:  Ayobami T Akenroye; Tonya Brunetti; Karina Romero; Michelle Daya; Kanika Kanchan; Gautam Shankar; Sameer Chavan; Meher Preethi Boorgula; Elizabeth A Ampleford; Héllen Freitas Fonseca; Gregory A Hawkins; Helena Mariana Pitangueira Teixeira; Monica Campbell; Nicholas Rafaels; Alexandra Winters; Eugene R Bleecker; Alvaro A Cruz; Mauricio L Barreto; Deborah A Meyers; Victor E Ortega; Camila A Figueiredo; Kathleen C Barnes; William Checkley; Nadia N Hansel; Rasika A Mathias
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 10.793

6.  An Effective Hypoxia-Related Long Non-Coding RNA Assessment Model for Prognosis of Lung Adenocarcinoma.

Authors:  Yuanshuai Li; Xiaofang Sun
Journal:  Front Genet       Date:  2022-03-16       Impact factor: 4.599

Review 7.  Decoding LncRNAs.

Authors:  Lidia Borkiewicz; Joanna Kalafut; Karolina Dudziak; Alicja Przybyszewska-Podstawka; Ilona Telejko
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.